Results 461-480 of 1,215,952 for in 'Dáil debates' OR in 'Committee meetings' (speaker:Rory O'Hanlon OR speaker:Peter Fitzpatrick OR speaker:Seán Sherlock OR speaker:Joe McHugh OR speaker:Aindrias Moynihan OR speaker:Cathal Berry OR speaker:Micheál Martin OR speaker:Helen McEntee OR speaker:Matt Carthy OR speaker:Louise O'Reilly OR speaker:Johnny Mythen OR speaker:Michael Healy-Rae OR speaker:Catherine Connolly OR speaker:Pearse Doherty OR speaker:Michael McGrath OR speaker:Jim O'Callaghan OR speaker:Thomas Gould OR speaker:Seán Ó Fearghaíl OR speaker:Pauline Tully OR speaker:Dara Calleary OR speaker:Pat Buckley OR speaker:Imelda Munster OR speaker:Alan Farrell OR speaker:Paul McAuliffe OR speaker:Francis Noel Duffy OR speaker:Brendan Griffin OR speaker:Éamon Ó Cuív OR speaker:Brian Stanley OR speaker:Duncan Smith OR speaker:Mattie McGrath OR speaker:Roderic O'Gorman OR speaker:Catherine Martin OR speaker:Joe O'Brien OR speaker:Peadar Tóibín OR speaker:Steven Matthews OR speaker:Jennifer Carroll MacNeill OR speaker:Pádraig Mac Lochlainn OR speaker:Carol Nolan OR speaker:David Cullinane OR speaker:John McGuinness OR speaker:Bríd Smith OR speaker:Neasa Hourigan OR speaker:Éamon Ó Cuív42 OR speaker:Christopher O'Sullivan OR speaker:Thomas Pringle OR speaker:Éamon Ó Cuív61 OR speaker:Holly Cairns OR speaker:Alan Dillon OR speaker:Seán Crowe)

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: Am I right in thinking, just having sat on the task force a few times, that one of the answers to this is peer support, namely, that people would have a health advocate to sit with them and bring them back? In Mr. McCarthy's experience, is that something that works?

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: There are not enough people.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: I am always the boring person who says it is really cost-effective.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: It is just somebody who rings you up, reminds you not to forget about your appointment and walks in with you.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: When that happens, in Mr. Perth's experience, what is the language that is used? Is it said the people need to go and get treatment for bipolar first?

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: It is that dual diagnosis thing that they just will not do it.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: Am I right in thinking that if people go in somewhere with bipolar or whatever it might be to ask for treatment, they will often be told they need to get clean first?

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: It is a catch-22.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Neasa Hourigan: They would be turned away.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Seán Crowe: We were talking about the whole area of youth through the justice system and the lens of it. Again, it seems to be that if you are seen as a potential problem, the supports, the funding or group is there in relation to it, as Mr. Perth mentioned in his opening statement. We seem to pigeonhole young people who are a potential problem. All of a sudden, there is funding there in the justice...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I acknowledge the Cathaoirleach's new position. I have no doubt but that she will continue the good work of the previous Chair in chairing this committee and doing it in a cross-party way. Our work in this committee is very important, but so is the way we do our work. It is important and different from other committees. I acknowledge this point. I thank Mr. Gloster and all the team for...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I saw a figure regarding the outpatient waiting lists having been reduced by 50,000 people. Mr. Gloster is saying this is a real reduction rather than a validation exercise.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: Will Mr. Gloster repeat that figure?

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I accept that point. The experience just shone a light on the outpatients waiting list for me.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: We do not know, but this may be the last or the second last meeting of this committee. It will certainly be the last meeting during this Dáil when Mr. Gloster will be before us anyway.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I am very much cognisant of the volume of money associated with this hearing. We are talking about €23.5 billion. Many Government Departments could be folded into that figure. In 2019, the figure was €16 billion. Essentially, there has been a 46% increase in the funding of the HSE over the past four years, that is, the lifetime of this Government. In 60 seconds, can Mr....

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I would love to explore that point more but I just do not have the time. Turning to the non-compliant procurement, this is the first thing we look at in this committee. The HSE estimated that the total expenditure on goods and services subject to procurement rules was €4.2 billion. Again, this amount is multiples of an entire Government Department in some cases. The idea that...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: When the HSE did the self-assessed audit, there was a very significant percentage of either non-co-operation or where you could not identify the purchaser. The figure of 12% actually could be higher.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: Just to return to that point, Mr. Mulvany is saying the figure of 12% does include the 13% of invoices within the scope of the exercise where either the manager responsible could not be identified or where the manager failed to respond to the exercise. He is saying that 13% is deemed non-compliant and is included in the 12%.